| Date Filed | Type | Description |
| 08/11/2023 |
SC 13D/A
| Novo Holdings A/S reports a 12% stake in IO Biotech, Inc. |
| 08/03/2023 |
SC 13D/A
| Novo Holdings A/S reports a 4.4% stake in Cyteir Therapeutics, Inc. |
| 07/26/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/28/2023 |
SC 13G/A
| Novo Holdings A/S reports a 4.8% stake in Disc Medicine, Inc. |
| 06/28/2023 |
SC 13G/A
| Novo Holdings A/S reports a 4.9% stake in Galera Therapeutics, Inc. |
| 06/28/2023 |
SC 13D/A
| Novo Holdings A/S reports a 9.6% stake in Edgewise Therapeutics, Inc. |
| 05/26/2023 |
SC 13G/A
| Novo Holdings A/S reports a 0% stake in VectivBio Holding AG |
| 05/15/2023 |
SC 13D/A
| Novo Holdings A/S reports a 10.2% stake in Reneo Pharmaceuticals, Inc. |
| 02/24/2023 |
SC 13D/A
| Novo Holdings A/S reports a 11.7% stake in LAVA Therapeutics N.V. |
| 02/02/2023 |
SC 13G/A
| Novo Holdings A/S reports a 5.3% stake in VectivBio Holding AG |
| 02/02/2023 |
SC 13G/A
| Novo Holdings A/S reports a 9.8% stake in Evotec SE |
| 01/04/2023 |
SC 13D/A
| Novo Holdings A/S reports a 0% stake in Bolt Biotherapeutics, Inc. |
| 01/03/2023 |
SC 13G
| Novo Holdings A/S reports a 13.8% stake in Disc Medicine, Inc. |
| 12/28/2022 |
SC 13D/A
| Novo Holdings A/S reports a 6.7% stake in Bolt Biotherapeutics, Inc. |
| 12/12/2022 |
SC 13G/A
| Novo Holdings A/S reports a 4% stake in Arcellx, Inc. |
| 11/28/2022 |
SC 13G/A
| Novo Holdings A/S reports a 5.7% stake in Arcellx, Inc. |
| 11/17/2022 |
SC 13G
| Novo Holdings A/S reports a 6.2% stake in Rallybio Corporation |
| 11/03/2022 |
SC 13G/A
| Novo Holdings A/S reports a 4.5% stake in Minerva Surgical, Inc. |
| 10/24/2022 |
SC 13D/A
| Novo Holdings A/S reports a 4.6% stake in Milestone Pharmaceuticals Inc. |
| 10/03/2022 |
SC 13D/A
| Novo Holdings A/S reports a 12.9% stake in LAVA Therapeutics N.V. |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/26/2022 |
SC 13D/A
| Novo Holdings A/S reports a 7% stake in Milestone Pharmaceuticals Inc. |
| 09/16/2022 |
SC 13D/A
| Novo Holdings A/S reports a 9.6% stake in Edgewise Therapeutics, Inc. |
| 08/18/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/02/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/22/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/15/2022 |
SC 13D/A
| Novo Holdings A/S reports a 9.8% stake in Bolt Biotherapeutics, Inc. |
|